Gilead Sciences, Inc. Stock Chart

Gilead Sciences, Inc. (XETR) · Health Technology. stock live price and technical analysis view. Follow XETRA data on Alerta Chart.

Checking data access...

About Gilead Sciences, Inc.

XETR
Market Cap
117.08B
P/E Ratio
21.85
Shares Out.
1.24B
Sector
Health Technology
Industry
Biotechnology

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

www.gilead.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free